Total Payments
$4,167
2024 Payments
$375.58
Companies
31
Transactions
186
Payment Breakdown by Category
Food & Beverage$4,166 (100.0%)
Education$1.21 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,166 | 185 | 100.0% |
| Education | $1.21 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $869.24 | 46 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $486.86 | 23 | $0 (2020) |
| ABBVIE INC. | $373.67 | 17 | $0 (2022) |
| Lundbeck LLC | $343.52 | 19 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $314.94 | 11 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $294.97 | 12 | $0 (2021) |
| Neos Therapeutics, LP | $233.50 | 6 | $0 (2017) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $129.45 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $124.69 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $375.58 | 3 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($129.45) |
| 2023 | $106.50 | 7 | Noven Therapeutics, LLC ($20.31) |
| 2022 | $126.32 | 5 | ABBVIE INC. ($126.32) |
| 2021 | $419.75 | 21 | AbbVie Inc. ($247.35) |
| 2020 | $465.91 | 23 | Allergan, Inc. ($352.38) |
| 2019 | $763.58 | 40 | Takeda Pharmaceuticals U.S.A., Inc. ($130.80) |
| 2018 | $730.55 | 34 | Otsuka America Pharmaceutical, Inc. ($193.01) |
| 2017 | $1,179 | 53 | Sunovion Pharmaceuticals Inc. ($349.53) |
All Payment Transactions
186 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/01/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $121.13 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $129.45 | General |
| Category: PSYCHIATRY | ||||||
| 08/17/2023 | Brainsway USA INC | — | Food and Beverage | Cash or cash equivalent | $7.80 | General |
| 06/16/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Central Nervous System | ||||||
| 05/26/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 04/14/2023 | Almatica Pharma LLC | SERTRALINE HCL (Drug), LOREEV XR | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: ANTI-DEPRESSION | ||||||
| 03/10/2023 | Noven Therapeutics, LLC | Secuado (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: CNS Psychiatry | ||||||
| 02/10/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: PSYCHIATRY | ||||||
| 01/21/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Neuropsychiatry | ||||||
| 10/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.49 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: NEUROLOGY | ||||||
| 09/24/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $17.22 | General |
| Category: Neurology | ||||||
| 08/27/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Geoffrey Dibella, M.D
Dr. Geoffrey Dibella, M.D is a Psychiatry healthcare provider based in Newport Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1982730230.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Geoffrey Dibella, M.D has received a total of $4,167 in payments from pharmaceutical and medical device companies, with $375.58 received in 2024. These payments were reported across 186 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,166).
Ad
Practice Information
- Specialty Psychiatry
- Location Newport Beach, CA
- Active Since 02/23/2007
- Last Updated 01/23/2009
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982730230
Products in Payments
- VRAYLAR (Drug) $1,243
- REXULTI (Drug) $539.75
- LATUDA (Drug) $486.86
- TRINTELLIX (Drug) $266.94
- Adzenys XR-ODT (Drug) $233.50
- CAPLYTA (Drug) $147.69
- Trintellix (Drug) $143.60
- COBENFY (Drug) $125.00
- Auvelity (Drug) $121.13
- AUSTEDO (Drug) $110.80
- INGREZZA (Drug) $96.00
- APLENZIN (Drug) $80.94
- MYDAYIS (Drug) $71.68
- VYVANSE (Drug) $60.99
- BELSOMRA (Drug) $46.63
- ADHANSIA XR (Drug) $42.09
- SPRAVATO (Drug) $41.28
- QUILLICHEW ER (Drug) $27.86
- OSMOLEX ER (Drug) $24.57
- NUPLAZID (Drug) $24.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Newport Beach
Dr. Nader Oskooilar, Md, MD
Psychiatry — Payments: $321,179
Psychiatry $321,179
Dr. Hadi Estakhri, M.d, M.D
Psychiatry — Payments: $16,721
Psychiatry $16,721
Dr. Venice Sanchez, M.d, M.D
Psychiatry — Payments: $16,294
Psychiatry $16,294
Dr. Hisham Korraa, M.d, M.D
Psychiatry — Payments: $14,252
Psychiatry $14,252
Dr. Stefani Lafrenierre, Md, MD
Psychiatry — Payments: $7,842
Psychiatry $7,842
Nimisha Jain, Pa, PA
Psychiatry — Payments: $6,289
Psychiatry $6,289